The Challenge

Over the past 60 years, despite the availability of antibiotics, infectious bacterial diseases have continued to cause massive global morbidity and mortality. Currently, infectious bacterial diseases account for more than 10 million deaths each year.

The problem is growing every day due to the lack of effective vaccines, rapidly increasing rates of antibiotic resistance, the emergence of new pathogens and the re-emergence of "old" pathogens in new guises.

Our Goal

The McDevitt laboratory is committed to dealing with infectious bacterial diseases in the 21st century using a two-pronged approach involving the development of cheaper and more effective vaccines, as well as engineering novel antibacterial drugs. These challenges require a thorough understanding of the biology of disease and the complex interaction between the bacterial pathogen and its host in order to develop the next generations of vaccines and drugs.

Meet the Team


Christopher McDevitt

ARC Future Fellow

Group Leader

Stephanie Neville

Passe & Williams Early Career Fellow

Aimee Tan

Senior Postdoctoral Researcher

Katie Ganio

Postdoctoral Researcher

Eve Maunders_400

Eve Maunders

Postdoctoral Researcher


Saleh Alquethamy

PhD Candidate


Marina Zupan

PhD Candidate

Navneet Kaur_400

Navneet Kaur

PhD Candidate

Chloe May Estoque_400

Chloe May Estoque

PhD Candidate

Matt Giles

Matt Giles

University of Melbourne

University of Toronto (Moraes Lab)

Joint PhD Candidate

Isabel Li_400

Isabel Li

Master of Biomedical Science

Abigail Rafa Hartono_400

Abigail Hartono

Honours Student

Salma Naleem Farook_400

Salma Naleem Farook

Honours Student

Alix Colafella_400

Alixandra Colafella

3rd Year Student